Victor Moyo
Chief Tech/Sci/R&D Officer at TRAWS PHARMA, INC.
Network origin in Victor Moyo first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Biotechnology | 13 | |
OncoPep, Inc.
OncoPep, Inc. Investment ManagersFinance OncoPep, Inc. develops immunotherapeutics to prevent the progression of cancer, prolong survival, and restore the quality of life of patients. The company?s product, PVX-410, is a multi-peptide therapeutic cancer vaccine to target specific antigens found on the surface of multiple myeloma cancer cells. Its PVX-410 is targeted for smoldering multiple myeloma, a precursor disease. The company was founded by Doris Peterkin, Joslyn Dobson, and Marc A. Cohen in 2010 and is headquartered in North Andover, MA.
9
| Holding Company | Investment Managers | 9 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Victor Moyo via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
EASTMAN KODAK COMPANY | Industrial Machinery | Founder | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
Rochester Christian University | College/University | Director/Board Member | |
INTERMUNE INC | Biotechnology | Sales & Marketing | |
Cernostics, Inc.
Cernostics, Inc. Medical SpecialtiesHealth Technology Cernostics, Inc. develops and commercializes cancer diagnostic tests. Its technology is based on a systems approach to evaluating tissues via anatomic pathology and simultaneously evaluates immune, stromal, stem cell and tumor biomarkers on a single slide while preserving tissue structure. The company was founded in 2008 by Michel Nederlof and Rebecca Critchley-Thorne and is headquartered in Pittsburgh, PA. | Medical Specialties | Director/Board Member | |
VIATAR CTC SOLUTIONS INC. | Medical Specialties | Director/Board Member | |
The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin | |
Metropolitan Opera Association, Inc.
Metropolitan Opera Association, Inc. Movies/EntertainmentConsumer Services Metropolitan Opera Association, Inc. organizes and performs opera shows in its residence at the Lincoln Center of Performing Arts. The firm offers services in association with sponsors, such as Texaco. It produces radio, television and compact disk recordings of the performances and distributes them around the world. The company was founded in 1883 and is headquartered in New York, NY. | Movies/Entertainment | Corporate Officer/Principal | |
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Hospital/Nursing Management | Director/Board Member Corporate Officer/Principal | |
Imperial College London | College/University | Undergraduate Degree Doctorate Degree | |
Nottingham Trent University | College/University | Undergraduate Degree | |
Lenel Systems International, Inc.
Lenel Systems International, Inc. Packaged SoftwareTechnology Services Lenel Systems International, Inc. provides software and integrated systems for the corporate and government security market. Its products include goVision, Onguard, Identitydefender and Hardware. The company was foundedby Rudy D. Prokupets in 1991 and Elena Prokupets and is headquartered in Pittsford, NY. | Packaged Software | Chief Executive Officer | |
DeSales University | College/University | Undergraduate Degree | |
Lake Forest College | College/University | Undergraduate Degree | |
INOVIO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
EG Capital Group LLC
EG Capital Group LLC Investment ManagersFinance EG Capital Group LLC (EG Capital) is a private equity firm founded in 2003 by Jay L. Eastman and Norm A. Gretzinger. The firm is headquartered in New York. | Investment Managers | Founder | |
National Academy of Medicine (United States)
National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
American Society of Hematology
American Society of Hematology Miscellaneous Commercial ServicesCommercial Services American Society of Hematology provides the most current practice tools, clinical support and educational products needed in hematology. The firm offers educational products and services for clinicians and scientists. The company is headquartered in Washington, DC. | Miscellaneous Commercial Services | President | |
The Multiple Myeloma Research Foundation, Inc.
The Multiple Myeloma Research Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services The Multiple Myeloma Research Foundation, Inc. provides funding for research on myeloma treatment. It provides funding to laboratories worldwide, including compounds and approaches in clinical trials and pre-clinical studies. The firm also facilitates clinical trials through their affiliate organization, the Multiple Myeloma Research Consortium. The company was founded by Karen E. Andrews and Kathryn E. Giusti in 1998 and is headquartered in Norwalk, CT. | Miscellaneous Commercial Services | Director/Board Member | |
King's College London | College/University | Graduate Degree | |
National Comprehensive Cancer Network, Inc.
National Comprehensive Cancer Network, Inc. Miscellaneous Commercial ServicesCommercial Services National Comprehensive Cancer Network, Inc. provides research and development services to fight against cancer. The organization develops resources that present information to the numerous stakeholders in the health care delivery system. The company was founded in 1995 and is headquartered in Fort Washington, PA. | Miscellaneous Commercial Services | Chairman | |
The Association of the British Pharmaceutical Industry
The Association of the British Pharmaceutical Industry Miscellaneous Commercial ServicesCommercial Services The Association of the British Pharmaceutical Industry is a non-profit organization, which engages in the research and development of medicines. It focuses on biosciences. The company is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
St. Petersburg State Electrotechnical University | College/University | Doctorate Degree | |
PHARMACYTE BIOTECH, INC. | Pharmaceuticals: Other | Director/Board Member | |
Columbia University Medical Center | College/University | Chairman | |
Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Acetylon Pharmaceuticals, Inc.
Acetylon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Acetylon Pharmaceuticals, Inc. develops pharmaceutical technology. It develops novel small molecule drugs which targets epigenetic mechanisms for the enhancement of therapeutic outcomes in cancer and other critical human diseases. The company was founded by Ralph Mazitschek, Kenneth C. Anderson, Marc A. Cohen, James E. Bradner, and Walter C. Ogier in October 2008 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Founder Director/Board Member Director/Board Member Founder | |
The Johns Hopkins University School of Medicine | College/University | Doctorate Degree | |
MEDEXUS PHARMACEUTICALS INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Medexus Pharma, Inc.
Medexus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Medexus Pharma, Inc. develops treatments for autoimmune diseases. It focuses on development and commercialization of treatments for autoimmune diseases as well as cancer. The company was founded in 2012 and is headquartered in Chicago, IL. | Pharmaceuticals: Major | Chief Executive Officer | |
C4 THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Chairman Director/Board Member Director/Board Member Founder | |
PDI, Inc.
PDI, Inc. Commercial Printing/FormsCommercial Services PDI, Inc. provides format printing services. It specializes in document management, electronic pre-media and on-site prepress management, to offset and full-color variable digital print, bindery, multimedia and internet services. The company was founded in February 2007 and is headquartered in Kirkland, Canada. | Commercial Printing/Forms | Director/Board Member | |
Regenacy Pharmaceuticals LLC
Regenacy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Regenacy Pharmaceuticals LLC operates as a clinical-stage biopharmaceutical company. It develops treatments for diabetic and peripheral neuropathies. The firm provides treatments through regeneration of normal protein function using oral, isoform selective histone deacetylase enzyme inhibitors. It provides treatment for diseases such as sickle cell disease, ß-thalassemia, leukemia, and cognitive dysfunction in neurological disorders. The company was founded by Marc A. Cohen in December 2016 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Founder Director/Board Member | |
Quadrant Pharmaceuticals LLC
Quadrant Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Quadrant Pharmaceuticals LLC manufactures pharmaceutical products. The private company is based in New York, NY. The company was founded by Jack E. Stover. | Pharmaceuticals: Major | Founder | |
JDRF T1D Fund
JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Director/Board Member | |
Mana Therapeutics, Inc.
Mana Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Mana Therapeutics, Inc. provides clinical cell immune therapies that can eliminate cancer cells. The company was founded by Catherine Bollard, Patrick Hanley, C. Russell Y. Cruz and Marc Cohen and is headquartered in Arlington, VA. | Miscellaneous Commercial Services | Founder Director/Board Member | |
Raqia Therapeutics, Inc. | Chairman Director/Board Member | ||
International Myeloma Society | President | ||
Starton Therapeutics, Inc.
Starton Therapeutics, Inc. BiotechnologyHealth Technology Starton Therapeutics, Inc. is a clinical-stage biotechnology platform company that focuses on transforming standard of care therapies with proprietary continuous delivery technology. The company is based in Paramus, NJ. The company's goal is to provide continuous treatment to people with cancer so they can live better and longer. Starton's proprietary transdermal technology is intended to increase the efficacy of approved drugs, make them more tolerable, and expand their potential use. The company was founded in 2017 by Pedro Lichtinger, who has been the CEO since 2017. | Biotechnology | Director/Board Member | |
NextRNA Therapeutics, Inc.
NextRNA Therapeutics, Inc. BiotechnologyHealth Technology NextRNA Therapeutics, Inc. is a biotechnology company that specializes in drug development services. The company is based in Cambridge, MA. The company was founded in 2021 by Leon Wert-Lamas, Marc A. Cohen, Julia Novina, Carl Novina, Dominique Verhelle, Kenneth C. Anderson, Robert S. Langer. Dominique Verhelle has been the CEO since 2021. | Biotechnology | Founder Director/Board Member Founder | |
CommBio Therapeutics Co., Ltd. | Chief Tech/Sci/R&D Officer | ||
NORTHVIEW ACQUISITION CORPORATION | Financial Conglomerates | Founder | |
Window Therapeutics, Inc.
Window Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Window Therapeutics, Inc. is an American company that engages in cancer therapy research. The company was founded by Yivan Jiang, Hung Nguyen, and Jeremiah Johnson. The CEO is Chih-Kao Hu. | Miscellaneous Commercial Services | Director/Board Member | |
K36 Therapeutics, Inc.
K36 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology K36 Therapeutics, Inc. develops small molecule therapeutics. The company is based in Cambridge, MA. The company was founded in 2021. The CEO is Terry Connolly. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
AI Proteins, Inc.
AI Proteins, Inc. Pharmaceuticals: MajorHealth Technology AI Proteins, Inc. is a biotech company based in Andover, MA. AI Proteins is focused on re-imagining protein therapeutics by designing entirely new proteins using an AI-based approach and a high-throughput drug discovery platform. The company's platform enables the development of inexpensive, durable, and highly specific proteins optimized for specific therapeutic applications. These proteins have the potential for oral delivery and can dramatically accelerate the development of lead therapeutic candidates ready for IND-enabling studies. The company was founded by Marc A. Cohen and Christopher Bahl. Noah D. Beerman has been the CEO of the company since 2023. | Pharmaceuticals: Major | Founder Director/Board Member | |
University of Liverpool | College/University | Undergraduate Degree |
Statistics
International
United States | 41 |
United Kingdom | 6 |
Canada | 3 |
Italy | 2 |
Russia | 2 |
Sectoral
Health Technology | 18 |
Consumer Services | 14 |
Commercial Services | 11 |
Finance | 4 |
Technology Services | 3 |
Operational
Director/Board Member | 75 |
Corporate Officer/Principal | 35 |
Founder | 22 |
Chairman | 20 |
Independent Dir/Board Member | 19 |
Most connected contacts
Insiders | |
---|---|
Marc A. Cohen | 21 |
Jack Stover | 19 |
Bruce Downey | 18 |
Viren Mehta | 17 |
Kenneth Anderson | 17 |
Elena Prokupets | 11 |
Steven Fruchtman | 11 |
James Marino | 10 |
Jay L. Eastman | 7 |
Mary Shoemaker | 7 |
Peter Atadja | 7 |
Jerome Groopman | 6 |
Matthew Parris | 5 |
Trafford Clarke | 5 |
Mark Guerin | 4 |
- Stock Market
- Insiders
- Victor Moyo
- Company connections